Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. - Kushner,B.H.; Kramer,K.; Cheung,N.K. (J Clin Oncol, 2001)